These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24312299)

  • 1. Serological response of patients with influenza A (H1N1) pdm09-associated pneumonia: an observational study.
    Angkasekwinai N; Kaewnapha B; Waywa D; Werarak P; Tongsai S; Chokephaibulkit K; Thamlikitkul V; Siritantikorn S
    PLoS One; 2013; 8(11):e81436. PubMed ID: 24312299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
    Liu W; Lien YH; Lee PI; Chan TC; Wang LC; Yang CR; Ho MS; Chen JR; Ku CC; King CC
    Vaccine; 2022 May; 40(24):3402-3411. PubMed ID: 35525727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.
    Tunheim G; Laake I; Robertson AH; Waalen K; Hungnes O; Naess LM; Cox RJ; Mjaaland S; Trogstad L
    Influenza Other Respir Viruses; 2019 Mar; 13(2):191-200. PubMed ID: 30536590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody persistence and serological protection among seasonal 2007 influenza A(H1N1) infected subjects: Results from the FLUREC cohort study.
    Delabre RM; Salez N; Lemaitre M; Leruez-Ville M; de Lamballerie X; Carrat F
    Vaccine; 2015 Dec; 33(49):7015-21. PubMed ID: 26387434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
    Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Serological Responses in Critically Ill Patients Hospitalized With 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009-2011.
    Rolfes MA; Gross FL; Flannery B; Meyers AFA; Luo M; Bastien N; Fowler RA; Katz JM; Levine MZ; Kumar A; Uyeki TM;
    J Infect Dis; 2018 Mar; 217(7):1078-1088. PubMed ID: 29342251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.
    Hsu JP; Zhao X; Chen MI; Cook AR; Lee V; Lim WY; Tan L; Barr IG; Jiang L; Tan CL; Phoon MC; Cui L; Lin R; Leo YS; Chow VT
    BMC Infect Dis; 2014 Jul; 14():414. PubMed ID: 25066592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.
    Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadière B; van der Werf S; Autran B; Carcelain G;
    Am J Respir Crit Care Med; 2014 May; 189(10):1240-9. PubMed ID: 24646009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus.
    Grund S; Adams O; Wählisch S; Schweiger B
    J Virol Methods; 2011 Feb; 171(2):369-73. PubMed ID: 21146560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.
    Chen MI; Barr IG; Koh GC; Lee VJ; Lee CP; Shaw R; Lin C; Yap J; Cook AR; Tan BH; Loh JP; Barkham T; Chow VT; Lin RT; Leo YS
    PLoS One; 2010 Aug; 5(8):e12474. PubMed ID: 20814575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study.
    Kang EK; Eun BW; Kim NH; Lim JS; Lee JA; Kim DH
    BMC Infect Dis; 2016 Aug; 16(1):438. PubMed ID: 27549626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.
    Makkoch J; Payungporn S; Prachayangprecha S; Tantilertcharoen R; Poovorawan Y
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):67-75. PubMed ID: 20527519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
    Veguilla V; Hancock K; Schiffer J; Gargiullo P; Lu X; Aranio D; Branch A; Dong L; Holiday C; Liu F; Steward-Clark E; Sun H; Tsang B; Wang D; Whaley M; Bai Y; Cronin L; Browning P; Dababneh H; Noland H; Thomas L; Foster L; Quinn CP; Soroka SD; Katz JM
    J Clin Microbiol; 2011 Jun; 49(6):2210-5. PubMed ID: 21471339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
    Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to influenza viruses in paediatric patients and their contacts at the onset of the 2009 pandemic in Mexico.
    Miranda-Novales G; Arriaga-Pizano L; Herrera-Castillo C; Pastelin-Palacios R; Valero-Pacheco N; Pérez-Toledo M; Ferat-Osorio E; Solórzano-Santos F; Vázquez-Rosales G; Espitia-Pinzón C; Zamudio-Lugo I; Meza-Chávez A; Klenerman P; Isibasi A; López-Macías C
    J Infect Dev Ctries; 2015 Mar; 9(3):259-66. PubMed ID: 25771463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.